Inato unveils trial matching tool claiming greater efficiency
The company updates its platform to allow sites to review upcoming trial opportunities and apply for the ones that are suitable for them and their patients.
Archives for November 14, 2022
Psychedelic startup launches with $60m and Catalent tech
Lusaris Therapeutics receives capital to develop LSR-1019, a potential psychedelic therapy for treatment-resistant depression.
With endpoints already met, GSK halts trial into new antibiotic
The first oral antibiotic treatment for urinary tract infections in over 20 years appears to be possible, after interim analysis advised for trials to be stopped after endpoints were met.